Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2.72 USD | +2.26% | +0.74% | +16.74% |
09/05 | Earnings Flash (VYNE) VYNE THERAPEUTICS Posts Q1 Revenue $98,000 | MT |
09/05 | VYNE Therapeutics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+16.74% | 37.5M | |
+39.56% | 723B | |
+34.12% | 595B | |
-3.00% | 369B | |
+20.08% | 332B | |
+2.20% | 282B | |
+17.04% | 244B | |
+9.49% | 208B | |
-4.95% | 205B | |
+1.21% | 168B |
- Stock Market
- Equities
- VYNE Stock
- News VYNE Therapeutics Inc.
- Transcript : Foamix Pharmaceuticals Ltd., Q2 2019 Earnings Call, Aug 08, 2019